Safety, Tolerability, and Immunogenicity of Two Formulations of V114 in Healthy Adults 50 Years of Age or Older (V114-006)
Clinical trial NCT02547649 · COMPLETED
Trial details
- NCT number
- NCT02547649
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-08
- Primary completion
- 2016-01-20
- Enrollment
- 690
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.